Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's revision badge was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision label updated to v3.4.3 in the page footer, replacing the previous v3.4.2.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 removed, reflecting a maintenance update on the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedA general site notice about a lapse in government funding and NIH operating status was added, directing users to cc.nih.gov and opm.gov for updates. The site revision version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check58 days agoChange DetectedAdded a 'Show glossary' option and new metadata items 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous metadata items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check72 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.